European Respiratory Review: 27 (149)

30 September 2018; volume 27, issue 149

Editorial

Open Access
Randomised controlled trials and real-life studies: two answers for one question
Sergio Harari

European Respiratory Review 27 (149) 180080; DOI: 10.1183/16000617.0080-2018 Published 26 September 2018

Open Access
Bronchiectasis: a case-based approach to investigation and management
Martina Contarini, Simon Finch, James D. Chalmers

European Respiratory Review 27 (149) 180016; DOI: 10.1183/16000617.0016-2018 Published 11 July 2018

Open Access
Systematic review of drug effects in humans and models with surfactant-processing disease
Dymph Klay, Thijs W. Hoffman, Ankie M. Harmsze, Jan C. Grutters, Coline H.M. van Moorsel

European Respiratory Review 27 (149) 170135; DOI: 10.1183/16000617.0135-2017 Published 11 July 2018
Open Access
Cardiovascular disease and COPD: dangerous liaisons?
Klaus F. Rabe, John R. Hurst, Samy Suissa

European Respiratory Review 27 (149) 180057; DOI: 10.1183/16000617.0057-2018 Published 3 October 2018
Open Access
How long is too long? A scoping review of health system delays in lung cancer
Ashanya Malalasekera, Sharon Nahm, Prunella L. Blinman, Steven C. Kao, Haryana M. Dhillon, Janette L. Vardy

European Respiratory Review 27 (149) 180045; DOI: 10.1183/16000617.0045-2018 Published 29 August 2018
Open Access
The broad spectrum of lung diseases in primary antibody deficiencies
Francesco Cinetto, Riccardo Scarpa, Marcello Rattazzi, Carlo Agostini

European Respiratory Review 27 (149) 180019; DOI: 10.1183/16000617.0019-2018 Published 29 August 2018

Open Access
Cadmium lung adsorption, citrullination and an enhanced risk of COPD
David Hutchinson

European Respiratory Review 27 (149) 180054; DOI: 10.1183/16000617.0054-2018 Published 26 September 2018